DK1379257T3 - Anticancer-profarmakon anvendende substituerede aromatiske syrer - Google Patents
Anticancer-profarmakon anvendende substituerede aromatiske syrerInfo
- Publication number
- DK1379257T3 DK1379257T3 DK02717687T DK02717687T DK1379257T3 DK 1379257 T3 DK1379257 T3 DK 1379257T3 DK 02717687 T DK02717687 T DK 02717687T DK 02717687 T DK02717687 T DK 02717687T DK 1379257 T3 DK1379257 T3 DK 1379257T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- substituted
- group
- alkyls
- substituted aromatic
- Prior art date
Links
- 230000001093 anti-cancer Effects 0.000 title 1
- 159000000032 aromatic acids Chemical class 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical class 0.000 abstract 2
- 125000004404 heteroalkyl group Chemical group 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004405 heteroalkoxy group Chemical group 0.000 abstract 1
- -1 heteroaromatic hydrocarbon Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyethers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27829801P | 2001-03-23 | 2001-03-23 | |
| PCT/US2002/008664 WO2002076476A2 (en) | 2001-03-23 | 2002-03-21 | Prodrugs of anticancer agents employing substituted aromatic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1379257T3 true DK1379257T3 (da) | 2009-12-14 |
Family
ID=23064458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02717687T DK1379257T3 (da) | 2001-03-23 | 2002-03-21 | Anticancer-profarmakon anvendende substituerede aromatiske syrer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6936597B2 (enExample) |
| EP (1) | EP1379257B1 (enExample) |
| JP (1) | JP4267326B2 (enExample) |
| AT (1) | ATE439147T1 (enExample) |
| CA (1) | CA2440091C (enExample) |
| DE (1) | DE60233315D1 (enExample) |
| DK (1) | DK1379257T3 (enExample) |
| ES (1) | ES2331562T3 (enExample) |
| MX (1) | MXPA03008192A (enExample) |
| WO (1) | WO2002076476A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6624142B2 (en) * | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
| ATE466953T1 (de) * | 2003-01-17 | 2010-05-15 | Advanced Proteome Therapeutics | Verfahren zur identifizierung aktivierter polymer-komplexe zur sekundären stellen-spezifischen modifikation von protein ziel-gruppen. |
| US7332164B2 (en) * | 2003-03-21 | 2008-02-19 | Enzon Pharmaceuticals, Inc. | Heterobifunctional polymeric bioconjugates |
| CZ294996B6 (cs) * | 2003-07-16 | 2005-04-13 | Ústav Makromolekulární Chemie Av Čr | Reaktivní polymery a kopolymery na bázi N-(2-hydroxypropyl)methakrylamidu, způsob jejich přípravy a jejich použití pro syntézu polymerních léčiv, pro modifikaci biologicky aktivních proteinů a přípravu systémů pro dopravu genů |
| WO2005030835A1 (ja) * | 2003-09-25 | 2005-04-07 | Terumo Kabushiki Kaisha | ポリエチレングリコール誘導体及びこれを膜構成成分とする薬物担体 |
| CN1889952A (zh) * | 2003-12-19 | 2007-01-03 | 诺瓦提斯公司 | (a)N－{5－[4－(4－甲基－(哌嗪－1－基)－甲基)－苯甲酰胺基]－2－甲基苯基}－4－(3－吡啶基)－2－嘧啶－胺和( b )至少一种羟丁赖氨酸形成抑制剂的组合产品及其用途 |
| US7282590B2 (en) * | 2004-02-12 | 2007-10-16 | The Research Foundation Of State University Of New York | Drug conjugates |
| EP2176404A4 (en) * | 2007-07-11 | 2014-11-19 | Belrose Pharma Inc | POLYMERIC DRUG DELIVERY SYSTEMS WITH AN AROMATIC ALLYLIC ACID |
| US20090016985A1 (en) * | 2007-07-11 | 2009-01-15 | Enzon Pharmaceuticals, Inc. | Polymeric drug delivery system containing a multi-substituted aromatic moiety |
| WO2009042064A2 (en) | 2007-09-21 | 2009-04-02 | Nektar Therapeutics Al, Corporation | Oligomer-nucleoside phosphate conjugates |
| AU2019296174B2 (en) | 2018-06-29 | 2021-10-07 | Changchun Changcheng Pharmaceutical Technology Co., LTD | Phosphorus-containing prodrugs of gemcitabine |
| US11364711B2 (en) | 2018-12-21 | 2022-06-21 | The Clorox Company | Multi-layer substrates comprising sandwich layers and polyethylene |
| CA3128040A1 (en) | 2019-04-02 | 2020-10-08 | The Clorox Company | Process for manufacturing multi-layer substrates comprising sandwich layers and polyethylene |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684728A (en) * | 1979-01-12 | 1987-08-04 | Bayer Aktiengesellschaft | Solubilizing biologically active compounds with reactive hydrogen atoms |
| GB8430253D0 (en) * | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
| US6610841B1 (en) * | 1997-12-18 | 2003-08-26 | Gilead Sciences, Inc. | Nucleotide-based prodrugs |
| US5482719A (en) * | 1992-10-30 | 1996-01-09 | Guillet; James E. | Drug delivery systems |
| AU6486494A (en) * | 1993-06-24 | 1995-01-05 | Siemens Aktiengesellschaft | Compound and method of applying anti-fouling coatings on medical devices |
| US5919455A (en) * | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5605976A (en) | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
| JP4038600B2 (ja) * | 1997-06-02 | 2008-01-30 | 日油株式会社 | ヒドロキシアルキルフェノン誘導体及びその用途 |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| US5965119A (en) | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| JP2000056428A (ja) * | 1998-08-12 | 2000-02-25 | Konica Corp | 熱現像写真感光材料 |
| JP3485024B2 (ja) * | 1999-05-20 | 2004-01-13 | 東亞合成株式会社 | ヌクレオチド化合物 |
| JP3485023B2 (ja) * | 1999-05-20 | 2004-01-13 | 東亞合成株式会社 | ヌクレオシド化合物 |
| EP1212034A1 (en) * | 1999-09-10 | 2002-06-12 | The Procter & Gamble Company | Enzyme inhibitors |
-
2002
- 2002-03-21 DE DE60233315T patent/DE60233315D1/de not_active Expired - Lifetime
- 2002-03-21 MX MXPA03008192A patent/MXPA03008192A/es active IP Right Grant
- 2002-03-21 EP EP02717687A patent/EP1379257B1/en not_active Expired - Lifetime
- 2002-03-21 WO PCT/US2002/008664 patent/WO2002076476A2/en not_active Ceased
- 2002-03-21 JP JP2002574989A patent/JP4267326B2/ja not_active Expired - Fee Related
- 2002-03-21 DK DK02717687T patent/DK1379257T3/da active
- 2002-03-21 ES ES02717687T patent/ES2331562T3/es not_active Expired - Lifetime
- 2002-03-21 CA CA2440091A patent/CA2440091C/en not_active Expired - Fee Related
- 2002-03-21 US US10/103,323 patent/US6936597B2/en not_active Expired - Fee Related
- 2002-03-21 AT AT02717687T patent/ATE439147T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20020193409A1 (en) | 2002-12-19 |
| MXPA03008192A (es) | 2004-01-29 |
| CA2440091C (en) | 2011-05-03 |
| EP1379257A4 (en) | 2005-02-02 |
| CA2440091A1 (en) | 2002-10-03 |
| WO2002076476A3 (en) | 2002-11-14 |
| JP4267326B2 (ja) | 2009-05-27 |
| ES2331562T3 (es) | 2010-01-08 |
| JP2004532301A (ja) | 2004-10-21 |
| DE60233315D1 (de) | 2009-09-24 |
| US6936597B2 (en) | 2005-08-30 |
| WO2002076476A2 (en) | 2002-10-03 |
| EP1379257B1 (en) | 2009-08-12 |
| EP1379257A2 (en) | 2004-01-14 |
| ATE439147T1 (de) | 2009-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1379257T3 (da) | Anticancer-profarmakon anvendende substituerede aromatiske syrer | |
| AU2690001A (en) | Luminescent polymer | |
| AUPP268898A0 (en) | High modulus polyurethane compositions | |
| KR100479182B1 (ko) | 폴리히드록시알카노에이트의 제조에 이용되는 미생물 | |
| WO2002085324A3 (en) | Pre-moistened antibacterial wipe | |
| AU2001292633A1 (en) | Imidate-containing fluoropolymer compositions | |
| DE50008127D1 (de) | Verwendung eines hochfluorierten oligomeren alkans in der ophthalmologie | |
| ES2102494T3 (es) | Acetoacetanilidas sustituidas con poli(oxidos de alquileno). | |
| WO2003024885A3 (en) | Workability-improving agents for cement compositions | |
| AU4983999A (en) | Coumarin and related aromatic-based polymeric prodrugs | |
| ATE245411T1 (de) | Verwendung in der kosmetik von einem organopolysiloxan als geliermittel sowie eine kosmetischen zusammensetzung dieses enthaltend | |
| DE60015866D1 (de) | Flammschutzmittel, flammgeschützte Harzzusammensetzung sowie daraus geformte Gegenstände | |
| DE60322565D1 (de) | Antistatika und davon abgeleitete polymerzusammensetzungen | |
| ATE280169T1 (de) | Serotonerge benzothiophene | |
| WO1999037291A3 (de) | Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe | |
| CA2515385A1 (en) | Novel polymer and process for producing the same | |
| WO2001060822A8 (fr) | Derives d'aminoacides et leur utilisation en tant qu'inhibiteurs de la nep, l'ace et l'ece | |
| EP1388540A4 (en) | ACRYLIC ESTERS AND THEIR USE | |
| WO2004106431A3 (en) | Curable polymer compound | |
| DK1826214T3 (da) | Sammensætning omfattende ferrocen-derivater og brændstofsammensætning omfattende sådanne derivater | |
| HK1049995A1 (zh) | 制备醚封的聚(烷氧基化)醇表面活性剂的方法 | |
| AU2001286046A1 (en) | Surfactant | |
| WO2003014094A3 (de) | Heterocyclylarylsulfonamide | |
| AU1975999A (en) | Cellulosic particles and methods of making them | |
| AR028537A1 (es) | Hidrazidas y alcoxiamidas inhibidoras de la angiogénesis |